Evolving treatment strategies in CML - moving from early and deep molecular responses to TKI discontinuation and treatment-free remission: is there a need for longer-term trial outcomes?
Ahmet Emre EskazanPublished in: British journal of clinical pharmacology (2018)
Keyphrases
- chronic myeloid leukemia
- clinical trial
- study protocol
- tyrosine kinase
- phase iii
- disease activity
- advanced non small cell lung cancer
- randomized controlled trial
- rheumatoid arthritis
- type diabetes
- gestational age
- combination therapy
- adipose tissue
- metabolic syndrome
- replacement therapy
- double blind
- smoking cessation